Alkhorayef opens pharmaceuticals factory and other key medical projects in Jeddah

JEDDAH — Minister of Industry and Mineral Resources Bandar Alkhorayef inaugurated an advanced pharmaceuticals factory, Bpharma, in Jeddah on Wednesday.He also opened new production lines across several medical supplies facilities during his visit to the first, second, and third industrial cities in Jeddah governorate, thus advancing the localization of priority industries and supporting the Kingdom’s health and pharmaceutical security goals. Among these projects, he inaugurated a factory for the production of intravenous solutions, eye drops, and cardiac and emergency medications, with an annual capacity of 450 million units. The project represents an investment of SR650 million, with 30 percent of the production aimed for export. The newly launched pharmaceuticals factory represents a national initiative with an initial investment of over SR450 million, expected to exceed SR650 million upon the completion of its second phase, indicating strong confidence in the sector’s growth. This marks a significant advancement in the Kingdom’s pharmaceutical sector and supporting efforts to localize drug manufacturing and enhance supply chain efficiency. The factory spans approximately 38,000 square meters and adheres to the highest engineering and operational standards, featuring full automation and advanced technologies to ensure high production efficiency and strict quality controls.It features advanced production lines for sterile products, initially capable of producing 250 million units annually, set to increase to over 450 million units in phase two. The product range includes critical care items, specialized medicines, and ophthalmic and respiratory products. The project is expected to create 250 jobs in the first phase and approximately 600 upon completion of the second phase, with a focus on developing national talent through specialized training. This initiative supports Saudi Vision 2030’s goals of localizing the pharmaceutical industry and enhancing national health security. Alkhorayef also laid the foundation stone for the expansion of a medical supplies factory, backed by a SR220 million investment, to meet domestic demand and support growth in regional exports. In addition, a new production line was launched at a health consumer products facility, with an investment of SR60 million and an annual output of 30 million units, 85 percent of which will be exported to GCC countries, East Asia, and North Africa.The pharmaceutical market in the Kingdom is the largest in the Middle East, with an estimated value exceeding SR50 billion. Between 2019 and 2024, the market grew by 41 percent, with the number of pharmaceutical factories reaching 58 and 176 medical device factories expanding by over 300 percent, thanks to the support of government agencies led by the Ministry of Industry and Mineral Resources.